Select Medical(SEM) - 2025 Q2 - Earnings Call Presentation

SEMPERIT GROUP H1 2025 EARNINGS PRESENTATION Manfred Stanek, CEO Helmut Sorger, CFO 13 August 2025 Agenda Overview (p.3) Operational Performance (p.4) Financial Performance (p.7) Outlook (p.15) Appendix (p.17) 2 Earnings Presentation H1 2025 I 13 August 2025 Overview H1 2025 Semperit gains momentum in Q2 2025: EBITDA significantly improved to EUR 19.6m (+76.2% qoq) Recovery in order activities continues after subdued development in January/February H1 still marked by challenging environment: EBITDA at EUR 3 ...